Is Ortho Clinical Diagnostics part of J&J?

Is Ortho Clinical Diagnostics part of J&J?

Linden, New Jersey, U.S. U.S. In 2014, The Carlyle Group purchased the company from Johnson & Johnson for $4.15 billion. Ortho Clinical Diagnostics now operated as an independent company, up until its acquisition by Quidel Corporation for $6 billion, on May 27th 2022.

When did J&J sell Ortho Clinical Diagnostics?

New Brunswick, NJ, June 30, 2014 — Johnson & Johnson (NYSE: JNJ) today announced that it has completed the divestiture of its Ortho-Clinical Diagnostics business to The Carlyle Group for approximately $4 billion, subject to customary adjustments.

Is Ortho Clinical Diagnostics publicly traded?

Ortho Clinical Diagnostics went public in January 2021, raising $1.3 billion in gross proceeds in an IPO.

Who bought Ortho Clinical Diagnostics?

Quidel
Quidel (Nasdaq:QDEL) announced today that it completed its $6 billion acquisition of Ortho Clinical Diagnostics (Nasdaq:OCDX).

Is Ortho Clinical Diagnostics a good company?

Ortho Clinical Diagnostics has an overall rating of 4.1 Average Rating out of 5, based on over 7 Ortho Clinical Diagnostics Review Ratings left anonymously by Ortho Clinical Diagnostics employees, which is 5% higher than the average rating for all companies on CareerBliss.

Does Carlyle Group still own Ortho Clinical Diagnostics?

The Carlyle Group Completes the Acquisition of Ortho-Clinical Diagnostics, Inc. (OCD) Washington, DC – Globalalternative asset manager The Carlyle Group(NASDAQ:CG) today completed the previously announced acquisition of Ortho-Clinical Diagnostics, Inc. (OCD) for approximately $4 billion.

When did Ortho Clinical Diagnostics go public?

January 28, 2021
Ortho Goes Public Ortho began trading on the Nasdaq Global Select Market on January 28, 2021, under the symbol OCDX.

How many employees does Ortho Clinical Diagnostics have?

4,400Ortho Clinical Diagnostics / Number of employees (2019)

How big is Ortho Clinical Diagnostics?

About us. Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care. More than 800,000 patients across the world are impacted by Ortho’s tests each day.

How many manufacturing sites does Ortho Clinical Diagnostics have?

two manufacturing sites
Ortho maintains three Rochester facilities, the Global Center of Excellence for Research & Development and two manufacturing sites.